Literature DB >> 29093323

Multiple-Locus Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Isolates between 2004 and 2014 in Yamagata, Japan: Change in Molecular Characteristics during an 11-year Period.

Yu Suzuki1,2, Junji Seto1, Yoshitaka Shimotai2, Tsutomu Itagaki3, Yuriko Katsushima4, Fumio Katsushima4, Tatsuya Ikeda1, Katsumi Mizuta1, Seiji Hongo2, Yoko Matsuzaki2.   

Abstract

Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata, Japan. The results were examined by considering the combination of the P1 type and prevalence of macrolide resistance-associated mutations. Four-locus (Mpn13-16) MLVA classified 347 strains into 9 MLVA types, including 3 major types: 3-5-6-2, 4-5-7-2, and 4-5-7-3. All type 3-5-6-2 strains (77 strains) were P1 type 2 variants (2a or 2c), while types 4-5-7-2 (181 strains) and 4-5-7-3 (75 strains) were P1 type 1. MLVA type 4-5-7-2 strains circulated and were dominant until 2010, accounting for 88.4% of the 121 strains isolated between 2004 and 2010. The prevalence of types 4-5-7-3 and 3-5-6-2 strains increased rapidly in 2011 and 2012, respectively, resulting in cocirculation of 3 MLVA types, including type 4-5-7-2, between 2011 and 2013. The prevalence of macrolide resistance-associated mutations in MLVA types 4-5-7-2, 4-5-7-3, and 3-5-6-2 strains was 59.7% (108/181), 25.3% (19/75), and 0% (0/77), respectively. Because the prevalence of macrolide resistance-associated mutations differed by current MLVA types in Yamagata, continued surveillance combined with molecular typing and identification of macrolide resistance-associated mutations is necessary.

Entities:  

Keywords:  MLVA; P1 type; VNTR; macrolide resistance; molecular epidemiology

Mesh:

Substances:

Year:  2017        PMID: 29093323     DOI: 10.7883/yoken.JJID.2017.276

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  8 in total

1.  Molecular characterization of Mycoplasma pneumoniae infections in Moscow from 2015 to 2018.

Authors:  Elena N Voronina; Maria A Gordukova; Irina E Turina; Olga V Mishukova; Maya A Dymova; Elena V Galeeva; Anatoliy A Korsunskiy; Maxim L Filipenko
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-10-27       Impact factor: 3.267

2.  Increased Macrolide Resistance Rate of M3562 Mycoplasma pneumoniae Correlated With Macrolide Usage and Genotype Shifting.

Authors:  Yacui Wang; Baoping Xu; Xirong Wu; Qingqin Yin; Yi Wang; Jieqiong Li; Weiwei Jiao; Shuting Quan; Lin Sun; Yonghong Wang; Adong Shen
Journal:  Front Cell Infect Microbiol       Date:  2021-05-12       Impact factor: 5.293

3.  Molecular Typing of Mycoplasma pneumoniae Strains in Sweden from 1996 to 2017 and the Emergence of a New P1 Cytadhesin Gene, Variant 2e.

Authors:  Karolina Gullsby; Björn Olsen; Kåre Bondeson
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

4.  Macrolide Resistance, Clinical Features, and Cytokine Profiles in Taiwanese Children With Mycoplasma pneumoniae Infection.

Authors:  Tsung-Hua Wu; Nancy M Wang; Fang-Ching Liu; Hui-Hsien Pan; Fang-Liang Huang; Yu-Ping Fang; Ting-Wei Chiang; Yu-Ying Yang; Chiah-Sing Song; Hsiang-Chin Wu; Chun-Yi Lee
Journal:  Open Forum Infect Dis       Date:  2021-08-09       Impact factor: 3.835

5.  Association of Tandem Repeat Number Variabilities in Subunit S of the Type I Restriction-Modification System with Macrolide Resistance in Mycoplasma pneumoniae.

Authors:  Joon-Kee Lee; Moon-Woo Seong; Ki-Wook Yun; Eun-Hwa Choi
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

6.  Clonal Expansion of Macrolide-Resistant Sequence Type 3 Mycoplasma pneumoniae, South Korea.

Authors:  Joon Kee Lee; Joon Ho Lee; Hyunju Lee; Young Min Ahn; Byung Wook Eun; Eun Young Cho; Hwa Jin Cho; Ki Wook Yun; Hoan Jong Lee; Eun Hwa Choi
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

7.  Genetic characterization of Mycoplasma pneumoniae isolated in Osaka between 2011 and 2017: Decreased detection rate of macrolide-resistance and increase of p1 gene type 2 lineage strains.

Authors:  Chihiro Katsukawa; Tsuyoshi Kenri; Keigo Shibayama; Kazuo Takahashi
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

8.  Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018.

Authors:  L Xiao; A E Ratliff; D M Crabb; E Mixon; X Qin; R Selvarangan; Y-W Tang; X Zheng; J Dien Bard; T Hong; M Prichard; E Brooks; S Dallas; L B Duffy; K B Fowler; T P Atkinson; K B Waites
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.